Rekah Pharmaceutical Industry Ltd. (TLV:REKA)
Israel · Delayed Price · Currency is ILS · Price in ILA 1,231.00
0.00 (0.00%)
Feb 17, 2026, 5:24 PM IDT
TLV:REKA Market Cap
TLV:REKA has a market cap or net worth of 140.51 million as of February 18, 2026. Its market cap has decreased by -11.31% in one year.
Market Cap
140.51M
Enterprise Value
270.09M
Revenue
300.24M
Ranking
n/a
PE Ratio
n/a
Stock Price
1,231.00
Market Cap Chart
Since April 5, 2005, TLV:REKA's market cap has increased from 107.92M to 140.51M, an increase of 30.20%. That is a compound annual growth rate of 1.27%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 17, 2026 | 140.51M | 12.52% |
| Dec 31, 2025 | 124.88M | -17.43% |
| Dec 31, 2024 | 151.24M | -10.35% |
| Dec 31, 2023 | 168.71M | -3.96% |
| Dec 29, 2022 | 175.67M | -33.89% |
| Dec 30, 2021 | 265.73M | -13.13% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Teva Pharmaceutical Industries | 124.16B |
| Danel (Adir Yeoshua) | 2.72B |
| BrainsWay | 1.59B |
| Kamada | 1.57B |
| Geffen Residence & Renewal | 261.36M |
| Epitomee Medical | 260.22M |
| Golden House | 169.44M |
| InterCure | 152.34M |